Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2002-03-27 | H. Stewart Parker (age 46) managed the formation of Targeted Genetics as a wholly owned subsidiary of Immunex Corporation and has served as president, chief executive officer and a director of Targeted Genetics since our inception in 1989. |
| 2003-03-27 | H. Stewart Parker (age 47) managed the formation of Targeted Genetics as a wholly owned subsidiary of Immunex Corporation and has served as president, chief executive officer and a director of Targeted Genetics since our inception in 1989. Ms. Parker also served as chairman of the board of CellExSys, Inc., our majority-owned cell therapy subsidiary, since December 2000. She serves on the board of directors and the executive committee of BIO, the primary trade organization for the biotechnology industry, and as a director of several privately-held companies. Directors who are employees of Targeted Genetics do not receive any fees for their services as directors. Ms. Parker's 2002 base salary was $364,000. |
| 2004-03-24 | H. Stewart Parker (age 48) has served as president, CEO and director since inception in 1989. She serves on the nominating committee. Directors who are employees do not receive fees for their services as directors. |
| 2005-04-14 | H. Stewart Parker (age 49) managed the formation of Targeted Genetics as a wholly owned subsidiary of Immunex Corporation ... and has served as president, chief executive officer and a director of Targeted Genetics since our inception in 1989. ... Directors who are employees of Targeted Genetics do not receive any fees for their services as directors. ... Summary Compensation Table ... H. Stewart Parker (1) President and Chief Executive Officer 2004 Salary $398,000 ... |
| 2006-03-29 | H. Stewart Parker (age 50) has served as president, chief executive officer and a director of Targeted Genetics since inception. Ms. Parker received an annual retainer of $10,000, $418,000 salary in 2005, and other compensation. She is not a member of any committees as she is an employee. |
| 2007-04-02 | H. Stewart Parker has served as our president, chief executive officer and a director since our formation in 1989. She is not independent and does not receive fees for services as director. |
| 2007-11-21 | H. Stewart Parker President and Chief Executive Officer |
| 2008-03-28 | H. Stewart Parker managed our formation as a wholly owned subsidiary of Immunex Corporation ... and has served as our president, chief executive officer and a director since our formation in 1989. ... Director Compensation Table for Fiscal Year 2007 ... H. Stewart Parker Fees Earned $0, Stock Awards $0, Option Awards $0, Total $0 ... She is not independent because she is employed as our president and chief executive officer. |
| 2020-03-06 | H. Stewart Parker (Director) listed as a current director. |
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-27 | Ms. Parker holds a B.A. in Slavic Language & Literature and an M.B.A. in Finance and International Business from the University of Washington. |
| 2024-04-25 | Ms. Parker holds a B.A. in Slavic Language & Literature and an M.B.A. in Finance and International Business from the University of Washington. |
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-28 | H. Stewart Parker, age 59, has been a member of our Board of Directors since June 2014. The Audit Committee currently consists of three directors: Mr. Cleveland, Ms. Parker and Ms. Ramasastry. Ms. Parker was appointed to the Audit Committee in June 2014. Director compensation table shows total compensation of $504,165. |
| 2016-04-25 | H. Stewart Parker, age 60, has been a member of our Board of Directors since June 2014. ... The Audit Committee currently consists of three directors: Mr. Cleveland, Ms. Parker and Ms. Ramasastry. ... Ms. Parker serves as a member of the Audit Committee. ... Following the Annual Meeting, the Compensation Committee will consist of Dr. Mento, Ms. Parker and Mr. Ringo. ... The Board also appointed H. Stewart Parker as a lead independent director of the Board, effective immediately following the Annual Meeting. ... H. Stewart Parker Fees Earned or Paid in Cash ($) 50,000, Option Awards ($) 65,223, Total ($) 115,223. |
| 2017-04-25 | H. Stewart Parker, age 61, has been a member of our Board of Directors since June 2014... Ms. Parker will serve as the Chair of the Board... The Compensation Committee consists of three directors: Dr. Mento, Ms. Parker and Mr. Ringo... The Nominating and Corporate Governance Committee consists of three directors: Mr. Ringo, Dr. Dilly and Ms. Parker. |
| 2018-04-24 | H. Stewart Parker, age 62, has been a member of our Board of Directors since June 2014. Ms. Parker currently serves as the Chair of the Board. The Compensation Committee consists of three directors: Dr. Mento, Ms. Parker and Dr. Jeffs. The Nominating and Corporate Governance Committee consists of three directors: Dr. Dilly, Ms. Parker and Dr. Jeffs. The following table sets forth certain information regarding the compensation of each non-employee director for service as a member of the Board of Directors during 2017. H. Stewart Parker: Total $128,218. |
| 2019-04-25 | H. Stewart Parker, age 63, has been a member of our Board of Directors since June 2014, and has been Chair since June 2017. The Compensation Committee consists of Drs. Mento and Jeffs and Ms. Parker. The Nominating and Corporate Governance Committee consists of Dr. Dilly, Ms. Parker and Dr. Jeffs. Director compensation table shows total compensation of $277,770. |
| 2020-04-02 | H. Stewart Parker, age 64, has been a member of our Board of Directors since June 2014, and has been Chair since June 2017. The Compensation Committee consists of three directors: Ms. Parker, Dr. Smith and Mr. Zakrzewski. The Nominating and Corporate Governance Committee consists of three directors: Dr. Dilly, Mr. Meyers and Ms. Parker. Ms. Parker received total compensation of $203,812. |
| 2021-04-02 | H. Stewart Parker, age 65, has been a member of our Board of Directors since June 2014, and has been Chair since June 2017. Ms. Parker has over 40 years of experience in the biotechnology industry. Prior to focusing on boards and consulting, she served as the Chief Executive Officer of The Infectious Disease Research Institute (IDRI), a not-for-profit global health Research institute from 2011 to 2013. In 1992, Ms. Parker founded Targeted Genetics Corporation, a publicly traded Seattle-based biopharmaceutical company formed to develop gene-based treatments for acquired and inherited diseases that became a world leader in adeno-associated virus, or AAV, gene therapy. She held the position of President and Chief Executive Officer and was a member of its board of directors from the company’s inception until 2008. Prior to founding Targeted Genetics, Ms. Parker served in various capacities at Immunex from 1981 through 1991, most recently as Vice President, Corporate Development. From 1991 to 1993, Ms. Parker served as President and a Director of Receptech Corporation, a company formed by Immunex in 1989 to accelerate the development of soluble cytokine receptor products. She has served on the board of directors and the executive committee of BIO, the primary trade organization for the biotechnology industry. She currently serves on the board of directors of Achieve Life Sciences, Inc., a public pharmaceutical company and previously served on the board of directors of Armata Pharmaceuticals, Inc., a public biotechnology company, from May 2019 to December 2020. Ms. Parker received her B.A. and M.B.A. from the University of Washington. The Nominating and Corporate Governance Committee and the Board believe that Ms. Parker’s senior executive experience in AAV gene therapy and biotechnology drug development provides valuable operational, commercial assessment and management skills to the Board. Ms. Parker serves as Chair of the Board. The Compensation Committee consists of three directors: Mr. Meyers, Dr. Smith and Mr. Zakrzewski. Mr. Zakrzewski serves as Chair of this committee. The Nominating and Corporate Governance Committee consists of three directors: Dr. Hillan, Dr. Markels and Ms. Parker. Ms. Parker serves as Chair of this committee. Ms. Parker received total compensation of $323,324 in 2020. |
| 2022-04-01 | H. Stewart Parker, age 66, has been a member of our Board of Directors since June 2014, and has been Chair since June 2017. The Nominating and Corporate Governance Committee consists of two directors: Dr. Markels and Ms. Parker. The following table sets forth certain information regarding the compensation of each non-employee director for service as a member of the Board of Directors during 2021. Ms. Parker total compensation was $298,062. |
| 2023-04-17 | H. Stewart Parker, age 67, has been a member of our Board of Directors since June 2014, and has been Chair since June 2017. ... Ms. Parker serves on the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee. |
| 2024-04-19 | H. Stewart Parker, age 68, has been a member of our Board of Directors since June 2014, and has been Chair of the Board since June 2017. ... Nominating and Corporate Governance Committee members include Ms. Parker. ... Director compensation table shows H. Stewart Parker total compensation as $99,281. |
Data sourced from SEC filings. Last updated: 2026-02-03